Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Neuron-Specific HuR-Deficient Mice Spontaneously Develop Motor Neuron Disease.

Sun K, Li X, Chen X, Bai Y, Zhou G, Kokiko-Cochran ON, Lamb B, Hamilton TA, Lin CY, Lee YS, Herjan T.

J Immunol. 2018 Jul 1;201(1):157-166. doi: 10.4049/jimmunol.1701501. Epub 2018 May 14. Erratum in: J Immunol. 2018 Sep 1;201(5):1600.

PMID:
29760195
2.

Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Tan S, Ding K, Chong QY, Zhao J, Liu Y, Shao Y, Zhang Y, Yu Q, Xiong Z, Zhang W, Zhang M, Li G, Li X, Kong X, Ahmad A, Wu Z, Wu Q, Zhao X, Lobie PE, Zhu T.

J Biol Chem. 2017 Aug 18;292(33):13551-13564. doi: 10.1074/jbc.M117.780973. Epub 2017 Jun 21.

3.

Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity.

Hostetter CL, Licata LA, Keen JC.

Cancer Lett. 2009 Mar 18;275(2):178-84. doi: 10.1016/j.canlet.2008.10.005. Epub 2008 Nov 13.

PMID:
19013015
4.

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.

Hostetter C, Licata LA, Witkiewicz A, Costantino CL, Yeo CJ, Brody JR, Keen JC.

Cancer Biol Ther. 2008 Sep;7(9):1496-506. Epub 2008 Sep 23.

PMID:
18769129

Supplemental Content

Loading ...
Support Center